Gastric mucosal necrosis with vascular degeneration induced by doxycycline

American Journal of Surgical Pathology

Volumn 37, Issue 2, 2013, Pages 259-263

  Xiao, Shu Yuan ^a   Zhao, Lei ^a   Hart, John ^a   Semrad, Carol E ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

doxycycline; drug induced; erosion; gastric ulcer; gastropathy; toxic ischemic; vascular degeneration

Indexed keywords

ANTIINFECTIVE AGENT; DOXYCYCLINE;

ABDOMINAL PAIN; AGED; ARTICLE; CAPILLARY; CASE REPORT; CHEMICALLY INDUCED DISORDER; DIGESTIVE TRACT ENDOSCOPY; DRUG EFFECT; ESOPHAGITIS; FEMALE; HUMAN; NECROSIS; PATHOLOGY; PERIPHERAL VASCULAR DISEASE; REMISSION; STOMACH MUCOSA; TREATMENT OUTCOME; TREATMENT WITHDRAWAL; VASCULARIZATION;

ABDOMINAL PAIN; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CAPILLARIES; DOXYCYCLINE; ENDOSCOPY, DIGESTIVE SYSTEM; ESOPHAGITIS; FEMALE; GASTRIC MUCOSA; HUMANS; NECROSIS; PERIPHERAL VASCULAR DISEASES; REMISSION INDUCTION; TREATMENT OUTCOME; WITHHOLDING TREATMENT;

EID: 84872870481     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e31826602d8     Document Type: Article

References (17)

1. Tahan V, Sayrak H, Bayar N, et al. Doxycycline-induced ulceration mimicking esophageal cancer. Cases J. 2008;1:144-146.
2. del Valle Garcia Sanchez M, Gomez Camacho F, Poyato Gonzalez A, et al. Doxycycline-induced esophageal ulcer. Gastroenterol Hepatol. 2001;24:390-391.
3. Papazian A, Capron JP, Dupas JL. Doxycycline-induced esophageal ulcer: value of Lugol's solution vital staining. Gastrointest Endosc. 1981;27:201.
4. Sherman A, Bini EJ. Pill-induced gastric injury. Am J Gastroenterol. 1999;94:511-513.
5. Akbayir N, Alkim C, Erdem L, et al. A case report of doxycycline induced esophageal and gastric ulcer. Turk J Gastroenterol. 2002;13: 232-235.
6. Fries JF, Williams CA, Bloch DA, et al. Nonsteroidal antiinflammatory drug-associated gastropathy: incidence and risk factor models. Am J Med. 1991;91:213-222.
7. Fries JF. NSAID gastropathy: the second most deadly rheumatic disease? Epidemiology and risk appraisal. J Rheumatol Suppl. 1991; 28:6-10.
8. Parfitt JR, Driman DK. Pathological effects of drugs on the gastrointestinal tract: a review. Hum Path. 2007;38:527-536.
9. Melton-Celsa A, Mohawk K, Teel L, et al. Pathogenesis of Shigatoxin producing escherichia coli. Curr Top Microbiol Immunol. 2012;357:67-103.
10. Eisenhauer PB, Jacewicz MS, Conn KJ, et al. Escherichia coli Shiga toxin 1 and TNF-alpha induce cytokine release by human cerebral microvascular endothelial cells. Microb Pathog. 2004;36:189-196.
11. Karpman D, Connell H, Svensson M, et al. The role of lipopolysaccharide and Shiga-like toxin in a mouse model of Escherichia coli O157:H7 infection. J Infect Dis. 1997;175:611-620.
12. Lee CZ, Yao JS, Huang Y, et al. Dose-response effect of tetracyclines on cerebral matrix metalloproteinase-9 after vascular endothelial growth factor hyperstimulation. J Cereb Blood Flow Metab. 2006;26:1157-1164.
13. Lee CZ, Xu B, Hashimoto T, et al. Doxycycline suppresses cerebral matrix metalloproteinase-9 and angiogenesis induced by focal hyperstimulation of vascular endothelial growth factor in a mouse model. Stroke. 2004;35:1715-1719.
14. Carmack S, Vemulapalli R, Spechler S, et al. Esophagitis dissecans superficialis ("sloughing esophagitis"): a clinicopathologic study of 12 cases. Am J Surg Path. 2009;23:1789-1794.
15. Westerhoff M, Tretiakova M, Hovan L, et al. CD61, CD31, and CD34 improve diagnostic accuracy in gastric antral vascular ectasia and portal hypertensive gastropathy: An immunohistochemical and digital morphometric study. Am J Surg Pathol. 2010;34:494-501.
16. Jabbari M, Cherry R, Lough JO, et al. Gastric antral vascular ectasia: the watermelon stomach. Gastroenterol. 1984;87:1165-1170.
17. Payen JL, Cales P, Voigt JJ, et al. Severe portal hypertensive gastropathy and antral vascular ectasia are distinct entities in patients with cirrhosis. Gastroenterol. 1995;108:138-144.